Search Results - Dean Schraufnagel, MD

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Select octogenarians with stage IIIa non–small cell lung cancer can benefit from trimodality therapyCentral MessagePerspective

    Select octogenarians with stage IIIa non–small cell lung cancer can benefit from trimodality therapyCentral MessagePerspective by Andrew Tang, MD, MS, Andrew Feczko, MD, Sudish C. Murthy, MD, PhD, Siva Raja, MD, PhD, Alejandro Bribriesco, MD, Dean Schraufnagel, MD, Usman Ahmad, MD, Daniel P. Raymond, MD, Monisha Sudarshan, MD, MPH

    Published in JTCVS open
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease

    Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease by Tashkin, Donald P, Elashoff, Robert, Clements, Philip J, Roth, Michael D, Furst, Daniel E, Silver, Richard M, Goldin, Jonathan, Arriola, Edgar, Strange, Charlie, Bolster, Marcy B, Seibold, James R, Riley, David J, Hsu, Vivien M, Varga, John, Schraufnagel, Dean, Theodore, Arthur, Simms, Robert, Wise, Robert, Wigley, Fred, White, Barbara, Steen, Virginia, Read, Charles, Mayes, Maureen, Parsley, Ed, Mubarak, Kamal, Connolly, M. Kari, Golden, Jeffrey, Olman, Mitchell, Fessler, Barri, Rothfield, Naomi, Metersky, Mark, Khanna, Dinesh, Li, Ning, Li, Gang, Scleroderma Lung Study Research Group

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: